REVOLUTIONIZING
HEALTHCARE

THE FUTURE IS NOW

Our mission

Saving lives and reducing cost through the development of accessible and easy-to-use diagnostic tests.

‘Together with a strong international network of world leading academic and corporate partners, Qurin is developing a revolutionary, low threshold nanotechnology-based platform for (early) diagnosis, monitoring and personalized treatment of cancer and other medical conditions using urine as a liquid biopsy.’

WHAT WE DO

Saving lives

by early diagnostics

Detect cancer early

when it can be cured

Nanotechnology

and clinical expertise

We care

about saving lives

Nanotechnology changes the current health paradigm.”

We bring together the expertise for nanotechnology-enabled diagnostics.

‘At Qurin Diagnostics we leverage the power of state-of-the-art nanotechnology through the development of a versatile diagnostic technology platform for noninvasive testing. Current developments are focused on advanced biochip technology suitable for multiple biological and biomedical applications.’

Read more

In the SensorChip project, new sensors are being developed to accurately measure the presence of biomarkers in bodily fluids.

The SensorChip project is partially funded as part of the European Union’s response to the COVID-19 pandemic.

GET IN TOUCH

    Find out how Qurin Diagnostics can help you take patient care to the next level.

    EMAIL
    info@qurin.com

    PHONE
    +31 (0)85 06 01 447 

    BUSINESS OFFICE
    Keizersgracht 62
    1015 CS Amsterdam
    The Netherlands

    TECH OFFICE
    Hengelosestraat 500
    7521 AN Enschede
    The Netherlands